drugset / Trial / NCT00092105

Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)

NCT00092105

Phase 3 Completed 58 enrolled Organon and Co
RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to determine the protective effect of an approved medication on asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure to cats.

Timeline

Start
2002-04-01
Primary completion
2003-01-01
Completion
2003-01-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified